Search results
FDA puts partial clinical hold on BioNTech’s ADC trial after fatalities
Clinical Trials Arena via Yahoo Finance· 1 day agoThe partial clinical hold follows BioNTech’s presentation of data from the Phase I trial at the...
Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma
MedPage Today· 6 days agoMedPage Today brought together three expert leaders in the field: Moderator Joseph Mikhael, MD, is...
Merus N.V. VP controller Harry Shuman sells shares worth over $475,000 By Investing.com
Investing.com· 7 days agoIn a recent transaction, Harry Shuman, the VP Controller and Principal Accounting Officer (PAO) of...
Surviving to Thriving: Enhancing QoL in Breast Cancer
Medscape· 6 days agoThe growing number of breast cancer survivors highlights the need for holistic and coordinated...
Performance of Large Language Models on Medical Oncology Examination Questions
Journal of the American Medical Association· 2 days agoThis cross-sectional study evaluates the accuracy of large language model (LLM) answers to examination-style multiple choice medical oncology questions and assessed whether errors in LLM responses would be likely to cause harm.
A Benefit to Add-On Abemaciclib in Advanced Breast Cancer?
Medscape· 7 days agoAdding abemaciclib to an aromatase inhibitor improved overall survival in HR+/HER2− advanced breast...
AI Enhances Readability of Cancer Information for Patients
Medscape· 3 days agoChatGPT improved the readability of cancer-related information on patient-facing websites, without...
FDA halts trial of BioNTech-MediLink ADC over 'significant risk of illness'
FierceBiotech· 2 days agoThe FDA has slammed the brakes on a trial of MediLink Therapeutics’ BioNTech-partnered antibody-drug...
Polycystic Ovarian Syndrome: New Science Offers Old Remedy
Medscape· 2 days agoAn ancient Chinese remedy for malaria could offer new hope to the 10% of reproductive-age women...
Zentalis' shares plunge 30% after FDA places WEE1 drug on partial hold over sepsis deaths
FierceBiotech· 1 day agoThe FDA has placed three trials of Zentalis’ WEE1 candidate on partial hold in the wake of two...